Tim M. Mayleben
2016 - Esperion Therapeutics
In 2016, Tim M. Mayleben earned a total compensation of $1.2M as President and Chief Executive Officer at Esperion Therapeutics, a 79% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $176,000 |
|---|---|
| Option Awards | $417,468 |
| Salary | $535,000 |
| Other | $85,436 |
| Total | $1,213,904 |
Mayleben received $535K in salary, accounting for 44% of the total pay in 2016.
Mayleben also received $176K in non-equity incentive plan, $417.5K in option awards and $85.4K in other compensation.
Rankings
In 2016, Tim M. Mayleben's compensation ranked 7,320th out of 14,075 executives tracked by ExecPay. In other words, Mayleben earned more than 48.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,320 out of 14,075 | 48th |
Division Manufacturing | 2,762 out of 5,489 | 50th |
Major group Chemicals And Allied Products | 904 out of 1,895 | 52nd |
Industry group Drugs | 703 out of 1,538 | 54th |
Industry Pharmaceutical Preparations | 560 out of 1,176 | 52nd |
Source: SEC filing on March 6, 2017.
Mayleben's colleagues
We found four more compensation records of executives who worked with Tim M. Mayleben at Esperion Therapeutics in 2016.
News
Landos Biopharma CEO Gregory Oakes receives $1.8M in 2022
April 19, 2023
Landos Biopharma Executive Vice President of Operations Jyoti RAC's 2021 pay jumps 195% to $2.8M
April 28, 2022
Esperion Therapeutics CEO Tim Mayleben's 2021 pay rises 19% to $8.2M
April 14, 2022
Esperion Therapeutics CEO Tim Mayleben's 2019 pay falls 89% to $1.1M
April 16, 2020
Esperion Therapeutics CEO Tim Mayleben's 2018 pay jumps 94% to $9.7M
April 18, 2019